Tepnel announces new DNA test for early detection of familial hypercholesterolaemia.

Just ahead of the expected release of clinical practice guidelines on Familial Hypercholesterolaemia (FH) by the influential National Institute for Clinical Excellence (NICE), Tepnel Life Sciences PLC (Tepnel) announced the launch of a DNA test for the early detection of familial hypercholesterolaemia (FH). The CE marked Elucigene FH20 kit, validated for in vitro diagnostic use, can rapidly determine the 20 genetic mutations most commonly found in a UK based population, that are responsible for the disease. The NICE consultation on a draft of guidelines for use by the National Health Service (NHS) in England and Wales is now being finalized with anticipated publication for Aug, …